|
|
|
|
|
|
|
| |
Follow Important Email Alerts on Individual Stocks from SpeculatingStocks.com.
Sign up for our Email Newsletter.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Top Stories Today 2m
| 
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
PulseStream: |
| |
A Stream of All Pulses on SpeculatingStocks Pulse. |
|
| |
SpecStream: |
| |
A Stream of Data from SpeculatingStocks Pages. |
|
| |
UserStream: |
| |
A Stream of Pulses from Users within Pulse. |
|
| |
EchoStream: |
| |
A Stream of Pulses that have been Echoed. |
|
| |
Trending Stock Screener: |
| |
The World's First Trending Stock Screener. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flu season is underway with influenza already "widespread" in Massachusetts according to the CDC. $VXRT getting attention as a flu play.
$VXRT should be catching your eye with a 5% move today on 496k volume, 3x average volume.
$VXRT has been charging hard in the afternoon of the past two trading sessions.
Investors haven't been giving $VXRT the respect it deserves for the $JNJ Janssen collaboration. If this relationship expands...!
$VXRT up 6% the past two days. It's seeing attention from new investors and volume 350k+ each day, most it's seen since earnings 8/9.
Now is the time to research $VXRT. Vaxart is collaborating with $JNJ's Janssen to evaluate an oral universal influenza vaccine.
The Sept. - Oct. move in $VXRT may be starting early this year. It had a significant move in the fall in 2016, 2017, and 2018.
2/2 $JNJ Janssen is interested enough to have a “research collaboration” with Vaxart $VXRT. This is huge for a $10 million dollar company.
1/2 Remember how undervalued $VXRT is and the promise that their oral vaccine technology holds!
Smart money is moving heavily into $VXRT, +20% so far today on huge gap higher, 2x average volume already.
If the $VXRT “research collaboration” relationship with $JNJ Janssen evolves, there is no telling how much interest this stock could get.
After stewing over $VXRT earnings, the real hidden gem is their relationship /w $JNJ Janssen, which can turn into a gold mine for each side.
$VXRT cash and cash equivalents stands at $16.3M as of the end of the quarter and has a market cap of only $9.15M.
The main takeaway from $VXRT earnings is that Phase 1b results on norovirus vaccine expected out in early Q4 of this year.
The great thing about $VXRT is that it’s basically undiscovered and ignored at the moment. It’s not already saturated with investors.
Look for Vaxart $VXRT earnings after the bell today, 8/8/19.
$VXRT earnings are expected to be out tomorrow, 8/8/19. The stock was up after last quarter’s earnings.
$VXRT Phase 1b & 2 norovirus results expected in 2nd half of 2019, we are only a month into the 2nd half of the year.
$VXRT is an opportunity here, smart money accumulating as the tree gets shaken. Some impatience has taken hold.
Rush to safety yesterday with the biggest winners being $UVXY $JNUG $TVIX $NUGT. Volatility with market losses and gold /w global economy.
2nd half of 2019 expected to be big for $VXRT /w Phase 1b & 2 norovirus results. Remember move $OTLK made after its "Buy" rating at sub-$1.
H.C. Wainwright initiated coverage & placed a "Buy" on $VXRT /w a $2 price target. Surprised an analyst didn't come on board earlier.
$VXRT +4% crossed over its 50-day MA on news. Expected to present positive preclinical on its RSV vaccine on Saturday.
$SONM now has 2 Followers, reaching a new follower milestone, with russurban just following Sonim Technologies Inc.
Phase 1b and Phase 2 results expected in the 2nd half of 2019 for $VXRT's norovirus vaccine.
Vaccine stock Vaxart $VXRT is due to heat up in the 2nd half of the year. It is one of the best bargains at its current level of 65 cents.
Wouldn’t be surprising to see Vaxart $VXRT get analyst news, may not happen, but it sure looks like a bargain at this level.
That $12 price target on Outlook Therapeutics $OTLK by Oppenheimer really soared the stock. It didn’t take a breather til this morning.
$TSLA Tesla is severely oversold at an RSI of 24, but that last quarter was horrible and they’ve been paying the price since.
Outlook Therapeutics $OTLK up 68% today on $12 price target placed on it by Oppenheimer.
It would not be shocking or surprising to see $VXRT challenge $0.83 - $0.84 today.
Outlook Therapeutics $OTLK is up 38% to $1.25 in the premarket on the $12 price target placed on it by Oppenheimer.
Only a matter of time before Wall Street recognizes the potential upside of vaccine stock Vaxart $VXRT.
russurban Placed a 'Buy' Sentiment on $OTLK (Outlook Therapeutics Inc.)
Outlook Therapeutics $OTLK, a $0.91 stock, $20M market cap biotech received an "outperform" rating & $12 price target on it by Oppenheimer.
Walmart ecommerce sales grew 37% with strong growth in online grocery and home and fashion sales. $WMT up 1.81% in premarket. Good results.
$WMT Walmart's first quarter earnings are out with EPS at $1.13 vs. estimates of $1.02. Same store sales +3.4%, beat expectations.
Futures are now surging with the DOW +82, NASDAQ +23, S&P +9. Big turnaround from overnight when futures were polar opposite.
As part of a class action, $GOOG Google Pixel owners affected by defective microphones could be paid up to $500. Big payout!
Futures have turned green after being deeply in the red overnight. It continues to be a bull market for the ages. Reminiscent of late 90s.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Reactions by russurban + @russurban Mentions |
 |
|
|
|
|
|
|
If $VXRT closes above $0.75 on Thursday or Friday, this could receive major attention and gap higher after that.
More than 2 wks ago | 0 buys, 0 sells
Moments ago | 0 buys, 0 sells
$VXRT is definitely acting differently and it closed over its 50-day moving average today.
More than 2 wks ago | 0 buys, 0 sells
The issue is that $TLRY lost $30.3 million for the quarter and trades at a market cap of $4.7 billion.
More than 3 mos ago | 0 buys, 0 sells
More than 3 mos ago | 0 buys, 0 sells
More than 3 mos ago | 0 buys, 0 sells
Moments ago | 0 buys, 0 sells
More than 3 mos ago | 0 buys, 0 sells
Looks like it's on a roll. $KGKG
More than 3 mos ago | 0 buys, 0 sells
However, Berkshire Hathaway now has major holdings in tech companies Apple $AAPL and Amazon $AMZN.
More than 3 mos ago | 0 buys, 0 sells
Beyond $BYND trades at a market cap of only $3.77 billion. It can see a higher valuation asa leader in plant-based meat.
More than 3 mos ago | 0 buys, 0 sells
Moments ago | 0 buys, 0 sells
This sort of money will be there for Tesla $TSLA until the shine wears off. Competition is catching up, took to long for Tesla to get here.
More than 3 mos ago | 0 buys, 0 sells
Hulu has live sports and has the backing of Disney $DIS which owns ESPN. $NFLX Netflix is in a predicament.
More than 3 mos ago | 0 buys, 0 sells
With Tesla $TSLA, it's as much or more about borrowing and debt as it is the business. They'll likely need to borrow further.
More than 3 mos ago | 0 buys, 0 sells
More than 3 mos ago | 0 buys, 0 sells
$VXRT reversal would have to be confirmed on Monday...
More than 3 mos ago | 0 buys, 0 sells
Offering free 1-day shipping to so many purchasers on Amazon $AMZN is the ultimate for the online retailer.
More than 3 mos ago | 0 buys, 0 sells
$TZOO beat earnings estimates by $0.13.
More than 3 mos ago | 0 buys, 0 sells
$LULU Lululemon CEO: The word 'athleisure' doesn’t define who we are
More than 3 mos ago | 0 buys, 0 sells
Moments ago | 0 buys, 0 sells
Microsoft $MSFT is seeing strong growth in the cloud with Azure.
More than 3 mos ago | 0 buys, 0 sells
$ARCI was the #4 gainer today, up 16%.
More than 3 mos ago | 0 buys, 0 sells
The problem with Tesla $TSLA now is that Wall Street may not trust Tesla's forecasts for upcoming quarters after such a bad quarter.
More than 3 mos ago | 0 buys, 0 sells
Tesla $TSLA is flat in AH.
More than 3 mos ago | 0 buys, 0 sells
Moments ago | 0 buys, 0 sells
$FB Facebook daily active users in US & Canada are flat in Q1.
More than 3 mos ago | 0 buys, 0 sells
Facebook $FB is up nearly 5% in After Hours.
More than 3 mos ago | 0 buys, 0 sells
Facebook $FB could get hit by an additional $2B expense.
More than 3 mos ago | 0 buys, 0 sells
$DIS Disney+ is cheaper at $6.99. It could cost $NFLX Netflix $117 million a month in revenue.
More than 3 mos ago | 0 buys, 0 sells
Moments ago | 0 buys, 0 sells
|
|
|
|
|
|
|
|
|
|
|
|
| |
Live Activity by russurban
|
|
|
|
|
|
|
|
|
|
|
|
| |
About Russ Urban |
 |
|
|
|
|
|
|
|
|
|
|
|
| |
Bio: Founder of SpeculatingStocks.com. Sending pulses out daily for pulse users. Msg me with ideas @russurban. Create an account!
|
|
| |
|
|
| |
Disclosure(s): I own shares of $VXRT. |
|
| |
|
|
| |
|
|
| |
|
|
| |
...is interested in large-caps, mega-caps, micro-caps, mid-caps, nano-caps and small-caps |
|
| |
|
|
| |
|
|
| |
|
|
| |
See Russ Urban's Stats Inside |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Discover & Discuss
All Stocks |
|
| |
Screen Trending Stocks |
|
| |
See B/S Today of Any Stock |
|
| |
Follow Stocks |
|
| |
Follow Key Stock Market Data |
|
| |
Find Similar Investors |
|
| |
Follow Investors and Traders |
|
| |
View the SpecStream |
|
| |
'Buy' / 'Sell' Pulses and Stocks |
|
| |
Place 'Buy' / 'Sell' Sentiments |
|
| |
Full 'Buy' / 'Sell' Stock Stats |
|
|
|
|
|
|
|
|
|
|
| |
The Revolution in Speculation Continues...
22,828 symbol pages... 1031
users... 2,009,355 pulses... not one
unhappy user. Sign up now, free!
Newest SpeculatingStocks Pulse User
Xclusive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Trending Stocks Within Pulse |
|
|
|
|
|
|
|
|
| |
SpeculatingStocks Pulse offers several trending stocks categories based on your market cap settings. Sign up for Pulse today. |
| |
|
|
|
|
|
|
|
|
|
|
